Perfusion Computed Tomography Scan Imaging in Differentiation of Benign from Malignant Parotid Lesions

Abstract

Introduction The most common site of salivary gland tumors is the parotid gland. Computed tomography (CT), magnetic resonance imaging (MRI), and sonography are imaging modalities to differentiate benign from malignant parotid tumors.

Objective The aim of this study is the evaluation of the diagnostic value of perfusion CT for differentiating histological categorization of benign and malignant parotid tumors.

Methods A total of 29 patients with parotid neoplasms were enrolled in this study. Mean age and all CT perfusion variables (gradient and permeability, blood flow [BF], blood volume [BV], mean transit time [MTT], permeability surface [PS], maximum intensity projection [MIP], time-density curve [TDC], and time to peak [TTP]) were compared among three groups (malignant tumors [MTs], Warthin's tumor [WT] and pleomorphic adenomas [PA]).

Results The mean age of the patients was 55.9 ± 14.1 (26–77), and 15 of them were male (51.7%). Eleven lesions were PAs [37.9%], 8 lesions were WTs (27.6%0 and 10 lesions (34.5%) were MTs (6 acinic cell carcinomas [ACCs], 3 adenocystic carcinomas [AdCCs], and 1 mucoepidermoid carcinoma [MEC]). The mean age of the patients with WTs was 62 ± 7.5 years; 52 ± 14.2 for patients with Pas, and 55.2 ± 17.2 for those with MTs (p = 0.32). The mean MIP was 122.7 ± 12.2 in WT, while it was 80.5 ± 19.5 in PA, and 76.2 ± 27.1 in MTs (p < 0.001); The mean MIP for WT was higher than for PAs and MTs; the values of MTs and PAs were not statistically different. The average of BF, BV, and curve peak were higher in WTs in comparison with the other two groups, and curve time 2 and TTP were higher in PAs in comparison with MTs.

Conclusion Based on this study, perfusion CT of the parotid gland and its parameters can distinguish between benign and malignant parotid masses.

Keywords

computed tomography - magnetic resonance imaging - parotid neoplasms - Warthin's tumor - pleomorphic adenoma

• References

• 1 Stenner M, Klussmann JP. Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved. European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology -. Head Neck Surg 2009; 266 (03) 333-341
• 2 Valstar MH, de Ridder M, van den Broek EC. , et al. Salivary gland pleomorphic adenoma in the Netherlands: A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence. Oral Oncol 2017; 66: 93-99
• 3 Bag AK, Curé JK, Chapman PR, Singhal A, Haneef Mohamed AW. Imaging of Inflammatory Disorders of Salivary Glands. Neuroimaging Clin N Am 2018; 28 (02) 255-272
• 4 Rumboldt Z, Al-Okaili R, Deveikis JP. Perfusion CT for head and neck tumors: pilot study. AJNR Am J Neuroradiol 2005; 26 (05) 1178-1185
• 5 Faggioni L, Neri E, Bartolozzi C. CT perfusion of head and neck tumors: how we do it. AJR Am J Roentgenol 2010; 194 (01) 62-69
• 6 Tawfik AM, Razek AA, Elhawary G, Batouty NM. Effect of increasing the sampling interval to 2 seconds on the radiation dose and accuracy of CT perfusion of the head and neck. J Comput Assist Tomogr 2014; 38 (03) 469-473
• 7 Bisdas S, Baghi M, Wagenblast J. , et al. Differentiation of benign and malignant parotid tumors using deconvolution-based perfusion CT imaging: feasibility of the method and initial results. Eur J Radiol 2007; 64 (02) 258-265
• 8 Knopf A, Mansour N, Chaker A, Bas M, Stock K. Multimodal ultrasonographic characterisation of parotid gland lesions--a pilot study. Eur J Radiol 2012; 81 (11) 3300-3305
• 9 Dong Y, Lei GW, Wang SW, Zheng SW, Ge Y, Wei FC. Diagnostic value of CT perfusion imaging for parotid neoplasms. Dentomaxillofac Radiol 2014; 43 (01) 20130237
• 10 Wang J, Tang Z, Wang S. , et al. Differential diagnostic value of computed tomography perfusion combined with vascular endothelial growth factor expression in head and neck lesions. Oncol Lett 2016; 11 (05) 3342-3348
• 11 Yang Z, Meng Q, Xu Q. , et al. Correlation between CT perfusion and vascular endothelial growth factor in neoplasm of head and neck. Zhonghua Fang She Xue Za Zhi 2007; 41 (09) 900-906
• 12 Abdel Razek AAK, Mukherji SK. State-of-the-Art Imaging of Salivary Gland Tumors. Neuroimaging Clin N Am 2018; 28 (02) 303-317
• 13 Razek AA, Tawfik AM, Elsorogy LG, Soliman NY. Perfusion CT of head and neck cancer. Eur J Radiol 2014; 83 (03) 537-544
• 14 Truong MT, Saito N, Ozonoff A. , et al. Prediction of locoregional control in head and neck squamous cell carcinoma with serial CT perfusion during radiotherapy. AJNR Am J Neuroradiol 2011; 32 (07) 1195-1201
• 15 Wang PZ, Yu Q, Shi HM, Luo JC. [Diagnostic value of CT perfusion for parotid gland tumors]. Shanghai Kou Qiang Yi Xue 2005; 14 (06) 573-577
• 16 Tawfik AM, Nour-Eldin NE, Naguib NN. , et al. CT perfusion measurements of head and neck carcinoma from single section with largest tumor dimensions or average of multiple sections: agreement between the two methods and effect on intra- and inter-observer agreement. Eur J Radiol 2012; 81 (10) 2692-2696
• 17 Tawfik AM, Razek AAA, Elsorogy LG. , et al. Perfusion CT of head and neck cancer: effect of arterial input selection. AJR Am J Roentgenol 2011; 196 (06) 1374-1380
• 18 Fischer T, Paschen CF, Slowinski T. , et al. Differentiation of parotid gland tumors with contrast-enhanced ultrasound. RoFo Fortschr Geb Rontgenstr Nuklearmed 2010; 182 (02) 155-162
• 19 Hayano K, Okazumi S, Shuto K. , et al. Perfusion CT can predict the response to chemoradiation therapy and survival in esophageal squamous cell carcinoma: initial clinical results. Oncol Rep 2007; 18 (04) 901-908
• 20 Ursino S, Faggioni L, Guidoccio F. , et al. Role of perfusion CT in the evaluation of functional primary tumour response after radiochemotherapy in head and neck cancer: preliminary findings. Br J Radiol 2016; 89 (1065): 20151070
• 21 Trojanowska A, Trojanowski P, Drop A, Jargiełło T, Klatka J. Head and neck cancer: value of perfusion CT in depicting primary tumor spread. Med Sci Monit 2012; 18 (02) CR112-CR118
• 22 Trojanowski P, Klatka J, Trojanowska A, Jargiełło T, Drop A. Evaluation of cervical lymph nodes with CT perfusion in patients with hypopharyngeal and laryngeal squamous cell cancer. Pol J Radiol 2011; 76 (01) 7-13